Trans Neuron Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
as on 16-11-2024
- Paid Up Capital ₹ 0.49 M
as on 16-11-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 16-11-2024
- Revenue 68.47%
(FY 2023)
- Profit 318.06%
(FY 2023)
- Ebitda 789.60%
(FY 2023)
- Net Worth 711.42%
(FY 2023)
- Total Assets 25.60%
(FY 2023)
About Trans Neuron Technologies
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹1.00 Cr.
Ruchi Sharma and Shivam Sharma serve as directors at the Company.
- CIN/LLPIN
U72300KA2015PTC083766
- Company No.
083766
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Trans Neuron Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchi Sharma  | Director | 29-Oct-2015 | Current |
| Shivam Sharma | Director | 29-Oct-2015 | Current |
Financial Performance of Trans Neuron Technologies.
Trans Neuron Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.47% increase. The company also saw a substantial improvement in profitability, with a 318.06% increase in profit. The company's net worth Soared by an impressive increase of 711.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trans Neuron Technologies?
In 2023, Trans Neuron Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Medihealth Care Private LimitedActive 22 years 8 monthsRuchi Sharma and Shivam Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Nov 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Trans Neuron Technologies?
Trans Neuron Technologies has a workforce of 122 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trans Neuron Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trans Neuron Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
